Assessing antigenic drift of seasonal influenza A(H3N2) and A(H1N1)pdm09 viruses

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Tewawong, Nipaporn ^a   Prachayangprecha, Slinporn ^a   Vichiwattana, Preeyaporn ^a   Korkong, Sumeth ^a   Klinfueng, Sirapa ^a   Vongpunsawad, Sompong ^a   Thongmee, Thanunrat ^a   Theamboonlers, Apiradee ^a   Poovorawan, Yong ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; VIRUS HEMAGGLUTININ; INFLUENZA VACCINE; VIRUS ANTIGEN;

ANTIGENIC DRIFT; ARTICLE; CLADISTICS; CONTROLLED STUDY; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC DRIFT; GENOME ANALYSIS; HUMAN; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; THAILAND; VIRUS GENOME; VIRUS STRAIN; ANTIGENIC VARIATION; GENETICS; IMMUNOLOGY; INFLUENZA; MOLECULAR EVOLUTION; SEASON; VIROLOGY;

ANTIGENIC VARIATION; ANTIGENS, VIRAL; EPITOPES; EVOLUTION, MOLECULAR; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; SEASONS; THAILAND;

EID: 84947718229     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0139958     Document Type: Article

References (46)

1. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003; 289(2): 179-86. PMID: 12517228
2. Pariani E, Amendola A, Ebranati E, Ranghiero A, Lai A, Anselmi G, et al. Genetic drift influenza A (H3N2) virus hemagglutinin (HA) variants originated during the last pandemic turn out to be predominant in the 2011-2012 season in Northern Italy. Infect Genet Evol. 2013; 13: 252-60. doi: 10.1016/j. meegid.2012.10.019 PMID: 23174527
3. Nicholson KG, Wood JM, Zambon M. Influenza. Lancet. 2003; 362(9397): 1733-45. PMID: 14643124
4. Krystal M, Elliott RM, Benz EW Jr., Young JF, Palese P. Evolution of influenza A and B viruses: conservation of structural features in the hemagglutinin genes. Proc Natl Acad Sci USA. 1982; 79(15): 4800-4. PMID: 6956892
5. De Jong JC, Rimmelzwaan GF, Fouchier RA, Osterhaus AD. Influenza virus: a master of metamorphosis. J Infect. 2000; 40(3): 218-28. PMID: 10908015
6. Bush RM, Bender CA, Subbarao K, Cox NJ, Fitch WM. Predicting the evolution of human influenza A. Science. 1999; 286(5446): 1921-5. PMID: 10583948
7. Fantoni A, Arena C, Corrias L, Salez N, de Lamballerie XN, Amoros JP, et al. Genetic drift of influenza A(H3N2) viruses during two consecutive seasons in 2011-2013 in Corsica, France. J Med Virol. 2014; 86(4): 585-91. doi: 10.1002/jmv.23745 PMID: 24105757
8. Huang JW, Yang JM. Changed epitopes drive the antigenic drift for influenza A (H3N2) viruses. BMC bioinformatics. 2011; 12 Suppl 1:S31. doi: 10.1186/1471-2105-12-S1-S31 PMID: 21342562
9. Kittikraisak W, Suntarattiwong P, Levy J, Fernandez S, Dawood FS, Olsen SJ, et al. Influenza vaccination coverage and effectiveness in young children in Thailand, 2011-2013. Influenza Other Respir Viruses. 2015; 9(2): 85-93. doi: 10.1111/irv.12302 PMID: 25557920
10. Gupta V, Earl DJ, Deem MW. Quantifying influenza vaccine efficacy and antigenic distance. Vaccine. 2006; 24(18): 3881-8. PMID: 16460844
11. Hoffmann E, Stech J, Guan Y, Webster RG, Perez DR. Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol. 2001; 146(12): 2275-89. PMID: 11811679
12. Suwannakarn K, Payungporn S, Chieochansin T, Samransamruajkit R, Amonsin A, Songserm T, et al. Typing (A/B) and subtyping (H1/H3/H5) of influenza A viruses by multiplex real-time RT-PCR assays. J Virol Methods. 2008; 152(1-2): 25-31. doi: 10.1016/j.jviromet.2008.06.002 PMID: 18598722
13. Prachayangprecha S, Makkoch J, Suwannakarn K, Vichaiwattana P, Korkong S, Theamboonlers A, et al. Epidemiology of seasonal influenza in Bangkok between 2009 and 2012. J Infect Dev Ctries. 2013; 7(10): 734-40. doi: 10.3855/jidc.2929 PMID: 24129626
14. Tewawong N, Suwannakarn K, Prachayangprecha S, Korkong S, Vichiwattana P, Vongpunsawad S, et al. Molecular epidemiology and phylogenetic analyses of influenza B virus in Thailand during 2010 to 2014. PloS one. 2015; 10(1):e0116302. doi: 10.1371/journal.pone.0116302 PMID: 25602617
15. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, et al. ClustalWand Clustal X version 2.0. Bioinformatics. 2007; 23(21): 2947-8. PMID: 17846036
16. Hasegawa M, Kishino H, Yano T. Dating of the human-ape splitting by a molecular clock of mitochondrial DNA. J Mol Evol. 1985; 22(2):160-74. PMID: 3934395
17. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol. 2013; 30(12): 2725-9. doi: 10.1093/molbev/mst197 PMID: 24132122
18. Macken C, Lu H, Goodman J, Boykin L. The value of a database in surveillance and vaccine selection. International Congress Series. 2001; 1219: 103-6.
19. Deem MW, Pan K. The epitope regions of H1-subtype influenza A, with application to vaccine efficacy. Protein Eng Des Sel. 2009; 22(9):543-6. doi: 10.1093/protein/gzp027 PMID: 19578121
20. Crooks GE, Hon G, Chandonia JM, Brenner SE. WebLogo: a sequence logo generator. Genome Res. 2004; 14(6): 1188-90. PMID: 15173120
21. Delport W, Poon AF, Frost SD, Kosakovsky Pond SL. Datamonkey 2010: a suite of phylogenetic analysis tools for evolutionary biology. Bioinformatics. 2010; 26(19): 2455-7. doi: 10.1093/bioinformatics/ btq429 PMID: 20671151
22. Gupta R, Jung E and Brunak S. Prediction of N-glycosylation sites in human proteins; 2004. Database: NetNGlyc 1.0 [Internet]. Accessed: http://www.cbs.dtu.dk/services/NetNGlyc/.
23. Pan K, Subieta KC, Deem MW. A novel sequence-based antigenic distance measure for H1N1, with application to vaccine effectiveness and the selection of vaccine strains. Protein Eng Des Sel. 2011; 24 (3): 291-9. doi: 10.1093/protein/gzq105 PMID: 21123189
24. Falchi A, Amoros JP, Arena C, Arrighi J, Casabianca F, Andreoletti L, et al. Genetic structure of human A/H1N1 and A/H3N2 influenza virus on Corsica Island: phylogenetic analysis and vaccine strain match, 2006-2010. PloS one. 2011; 6(9):e24471. doi: 10.1371/journal.pone.0024471 PMID: 21935413
25. Shao TJ, Li J, Yu XF, Kou Y, Zhou YY, Qian X. Progressive antigenic drift and phylogeny of human influenza A(H3N2) virus over five consecutive seasons (2009-2013) in Hangzhou, China. Int J Infect Dis. 2014; 29: 190-3. doi: 10.1016/j.ijid.2014.09.013 PMID: 25447724
26. Stevens J, Blixt O, Tumpey TM, Taubenberger JK, Paulson JC, Wilson IA. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science. 2006; 312(5772): 404-10. PMID: 16543414
27. Kryazhimskiy S, Plotkin JB. The population genetics of dN/dS. PLoS Genet. 2008 Dec; 4(12): e1000304. doi: 10.1371/journal.pgen.1000304 PMID: 19081788
28. Kilbourne ED. Influenza pandemics of the 20th century. Emerg Infect Dis. 2006; 12(1): 9-14. PMID: 16494710
29. Melidou A, Gioula G, Exindari M, Chatzidimitriou D,Malisiovas N. Genetic analysis of post-pandemic 2010-2011 influenza A(H1N1)pdm09 hemagglutinin virus variants that caused mild, severe, and fatal infections in Northern Greece. J Med Virol. 2015; 87(1): 57-67. doi: 10.1002/jmv.23990 PMID: 24898533
30. Widgren K, Magnusson M, Hagstam P, Widerstrom M, Ortqvist A, Einemo IM, et al. Prevailing effectiveness of the 2009 influenza A(H1N1)pdm09 vaccine during the 2010/11 season in Sweden. Euro Surveill. 2013; 18(15): 20447. PMID: 23594578
31. Rondy M, Launay O, Puig-Barbera J, Gefenaite G, Castilla J, de Gaetano Donati K, et al. 2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals. Euro Surveill. 2015; 20(2).
32. Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. Mapping the antigenic and genetic evolution of influenza virus. Science. 2004 Jul 16; 305(5682): 371-6. PMID: 15218094
33. Klein EY, Serohijos AW, Choi JM, Shakhnovich EI, Pekosz A. Influenza A H1N1 pandemic strain evolution- divergence and the potential for antigenic drift variants. PLoS One. 2014 Apr 3; 9(4):e93632. PMID: 24699432
34. Wilson IA, Cox NJ. Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol. 1990; 8: 737-71. PMID: 2188678
35. Shih AC, Hsiao TC, Ho MS, Li WH. Simultaneous amino acid substitutions at antigenic sites drive influenza A hemagglutinin evolution. Proc Natl Acad Sci USA. 2007; 104(15): 6283-8. PMID: 17395716
36. Bragstad K, Nielsen LP, Fomsgaard A. The evolution of human influenza A viruses from 1999 to 2006: a complete genome study. Virol J. 2008; 5: 40. doi: 10.1186/1743-422X-5-40 PMID: 18325125
37. Eshaghi A, Duvvuri VR, Li A, Patel SN, Bastien N, Li Y, et al. Genetic characterization of seasonal influenza A (H3N2) viruses in Ontario during 2010-2011 influenza season: high prevalence of mutations at antigenic sites. Influenza Other Respir Viruses. 2014; 8(2): 250-7. doi: 10.1111/irv.12219 PMID: 24313991
38. Nakajima K, Nobusawa E, Nagy A, Nakajima S. Accumulation of amino acid substitutions promotes irreversible structural changes in the hemagglutinin of human influenza AH3 virus during evolution. J Virol. 2005; 79(10): 6472-7. PMID: 15858030
39. Sun S, Wang Q, Zhao F, Chen W, Li Z. Prediction of biological functions on glycosylation site migrations in human influenza H1N1 viruses. PloS one. 2012; 7(2):e32119. doi: 10.1371/journal.pone. 0032119 PMID: 22355413
40. Suzuki Y. Positive selection for gains of N-linked glycosylation sites in hemagglutinin during evolution of H3N2 human influenza A virus. Genes Genet Syst. 2011; 86(5): 287-94. PMID: 22362027
41. Dawood FS, Prapasiri P, Areerat P, Ruayajin A, Chittaganpitch M, Muangchana C, et al. Effectiveness of the 2010 and 2011 Southern Hemisphere trivalent inactivated influenza vaccines against hospitalization with influenza-associated acute respiratory infection among Thai adults aged ≥50 years. Influenza Other Respir Viruses. 2014; 8(4): 463-8. doi: 10.1111/irv.12233 PMID: 24490684
42. Eick-Cost AA, Tastad KJ, Guerrero AC, Johns MC, Lee SE, Macintosh VH, et al. Effectiveness of seasonal influenza vaccines against influenza-associated illnesses among US military personnel in 2010- 11: a case-control approach. PloS one. 2012; 7(7):e41435. doi: 10.1371/journal.pone.0041435 PMID: 22859985
43. Bridges CB, Thompson WW, Meltzer MI, Reeve GR, Talamonti WJ, Cox NJ, et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial. JAMA. 2000; 284(13): 1655-63. PMID: 11015795
44. CDC. Early Estimates of Seasonal Influenza Vaccine Effectiveness-United States, January 2015. MMWR Morb Mortal Wkly Rep. 2015; 64(01): 10-5.
45. Huang JW, Lin WF, Yang JM. Antigenic sites of H1N1 influenza virus hemagglutinin revealed by natural isolates and inhibition assays. Vaccine 2012; 30: 6327-37. doi: 10.1016/j.vaccine.2012.07.079 PMID: 22885274
46. Caton AJ, Brownlee GG, Yewdell JW, Gerhard W. The antigenic structure of the influenza virus A/PR/ 8/34 hemagglutinin (H1 subtype). Cell. 1982; 31: 417-27. PMID: 6186384